Skip to Content

WPI 3721 (Lamotrigine (orally disintegrating) 25 mg)

Pill imprint WPI 3721 has been identified as Lamotrigine (orally disintegrating) 25 mg.

Lamotrigine is used in the treatment of bipolar disorder; schizoaffective disorder; borderline personality disorder; anxiety; seizure prevention (and more), and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 25 mg is not a controlled substance under the Controlled Substance Act (CSA).

Lamotrigine (orally disintegrating) 25 mg WPI 3721
Lamotrigine (orally disintegrating) 25 mg WPI 3721
Discount Card Promo
Lamotrigine (orally disintegrating)
WPI 3721
25 mg
Prescription only
Drug Class:
Triazine anticonvulsants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Global Pharmaceuticals

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.